These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 29292698)

  • 1. The potential role of exhaled breath analysis in the diagnostic process of pneumonia-a systematic review.
    van Oort PM; Povoa P; Schnabel R; Dark P; Artigas A; Bergmans DCJJ; Felton T; Coelho L; Schultz MJ; Fowler SJ; Bos LD
    J Breath Res; 2018 Feb; 12(2):024001. PubMed ID: 29292698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exhaled Breath Metabolomics for the Diagnosis of Pneumonia in Intubated and Mechanically-Ventilated Intensive Care Unit (ICU)-Patients.
    van Oort PM; de Bruin S; Weda H; Knobel HH; Schultz MJ; Bos LD; On Behalf Of The Mars Consortium
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
    Dallinga JW; Smolinska A; van Schooten FJ
    Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
    Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
    J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of volatile organic compounds in exhaled breath to diagnose ventilator-associated pneumonia.
    Schnabel R; Fijten R; Smolinska A; Dallinga J; Boumans ML; Stobberingh E; Boots A; Roekaerts P; Bergmans D; van Schooten FJ
    Sci Rep; 2015 Nov; 5():17179. PubMed ID: 26608483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous real-time breath analysis in ruminants: effect of eructation on exhaled VOC profiles.
    Oertel P; Küntzel A; Reinhold P; Köhler H; Schubert JK; Kolb J; Miekisch W
    J Breath Res; 2018 May; 12(3):036014. PubMed ID: 29648550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors that influence the volatile organic compound content in human breath.
    Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
    J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing patterns of volatile organic compounds exhaled in breath after consumption of two infant formulae with a different lipid structure: a randomized trial.
    Smolinska A; Baranska A; Dallinga JW; Mensink RP; Baumgartner S; van de Heijning BJM; van Schooten FJ
    Sci Rep; 2019 Jan; 9(1):554. PubMed ID: 30679671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exhaled breath profiling using broadband quantum cascade laser-based spectroscopy in healthy children and children with asthma and cystic fibrosis.
    van Mastrigt E; Reyes-Reyes A; Brand K; Bhattacharya N; Urbach HP; Stubbs AP; de Jongste JC; Pijnenburg MW
    J Breath Res; 2016 Apr; 10(2):026003. PubMed ID: 27058305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BreathDx - molecular analysis of exhaled breath as a diagnostic test for ventilator-associated pneumonia: protocol for a European multicentre observational study.
    van Oort PM; Nijsen T; Weda H; Knobel H; Dark P; Felton T; Rattray NJ; Lawal O; Ahmed W; Portsmouth C; Sterk PJ; Schultz MJ; Zakharkina T; Artigas A; Povoa P; Martin-Loeches I; Fowler SJ; Bos LD;
    BMC Pulm Med; 2017 Jan; 17(1):1. PubMed ID: 28049457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breathomics from exhaled volatile organic compounds in pediatric asthma.
    Neerincx AH; Vijverberg SJH; Bos LDJ; Brinkman P; van der Schee MP; de Vries R; Sterk PJ; Maitland-van der Zee AH
    Pediatr Pulmonol; 2017 Dec; 52(12):1616-1627. PubMed ID: 29082668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The versatile use of exhaled volatile organic compounds in human health and disease.
    Boots AW; van Berkel JJ; Dallinga JW; Smolinska A; Wouters EF; van Schooten FJ
    J Breath Res; 2012 Jun; 6(2):027108. PubMed ID: 22621865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
    Waltman CG; Marcelissen TAT; van Roermund JGH
    Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled breath compositions under varying respiratory rhythms reflects ventilatory variations: translating breathomics towards respiratory medicine.
    Sukul P; Schubert JK; Zanaty K; Trefz P; Sinha A; Kamysek S; Miekisch W
    Sci Rep; 2020 Aug; 10(1):14109. PubMed ID: 32839494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electronic nose based analysis of exhaled volatile organic compounds spectrum reveals asthmatic shifts and consistency in controls post-exercise and spirometry.
    Dragonieri S; Marco MD; Ahroud M; Quaranta VN; Portacci A; Iorillo I; Montagnolo F; Carpagnano GE
    J Breath Res; 2024 Jun; 18(3):. PubMed ID: 38876093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical use of exhaled volatile organic compounds in pulmonary diseases: a systematic review.
    van de Kant KD; van der Sande LJ; Jöbsis Q; van Schayck OC; Dompeling E
    Respir Res; 2012 Dec; 13(1):117. PubMed ID: 23259710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry.
    Purkhart R; Köhler H; Liebler-Tenorio E; Meyer M; Becher G; Kikowatz A; Reinhold P
    J Breath Res; 2011 Jun; 5(2):027103. PubMed ID: 21512209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.